Ask Warren

G2GBIO

456160 · KOSDAQ · ₩456160 · 지투지바이오

₩36,600▼ ₩1,300 (3.43%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Revenue₩1.6B₩351M₩203M₩58M₩153M₩7.9M−₩1.9M
Cost of sales₩896M₩164M₩193M₩161M₩103M₩518,800₩25M
Gross profit₩706M₩187M₩11M−₩102M₩51M₩7.3M−₩27M
Operating income−₩2.7B−₩3.3B−₩3B−₩3.6B−₩2.7B−₩2.9B−₩3.3B
Net income−₩174M−₩5.5B−₩8.6B−₩683M₩45M−₩2.9B−₩80B
Net income to shareholders−₩174M−₩5.5B−₩8.6B−₩683M₩45M−₩2.9B−₩80B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Total assets₩235B₩237B₩68B₩67B₩19B₩22B₩25B
Current assets₩220B₩222B₩53B₩53B₩5.2B₩7.9B₩11B
Cash and equivalents₩12B₩25B₩8B₩17B₩4.8B₩7B₩10B
Total liabilities₩96B₩93B₩9.4B₩9.2B₩9.8B₩9.8B₩145B
Current liabilities₩92B₩90B₩7.3B₩6.4B₩6.7B₩6.7B₩142B
Borrowings₩37B₩36B₩2.2B₩2.4B₩2.4B₩2.6B₩11B
Total equity₩139B₩144B₩58B₩58B₩9.5B₩12B−₩120B
Shareholders' equity₩139B₩144B₩58B₩58B₩9.5B₩12B−₩120B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Cash from operations−₩1.8B−₩3B−₩2.9B−₩6.5B−₩1.9B−₩2.7B−₩1.8B
Capital spending₩608M₩783M₩226M₩4.9M₩15M₩66M₩92M
Free cash flow−₩2.4B−₩3.8B−₩3.1B−₩6.5B−₩1.9B−₩2.8B−₩1.9B

Consolidated where available. Amounts in won.

Also known as: G2GBIO / 지투지바이오 / 456160 / KRX:456160

Source: KRX statistical information